No Data
US Stock MarketDetailed Quotes
NVTA Invitae
Watchlist
0.670
-0.028-4.04% Close 09/22 16:00 ET
0.675+0.005+0.73%
Post 19:41 ET
0.714High0.670Low8.62MVolume
0.709Open0.698Pre Close5.88MTurnover3.22%Turnover RatioLossP/E (TTM)181.20MMarket Cap3.77552wk HighLossP/E (Static)270.45MShares0.67052wk Low-0.90P/B179.73MFloat Cap61.590Historical High--Dividend TTM268.25MShs Float0.670Historical Low--Div YieldTTM6.32%Amplitude0.681Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Invitae Company
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Revenue Breakdown
Business
Unit:USD
Stock NameYOYOperating income%
Test revenue--500.56M96.95%
Other revenue--15.74M3.05%
News
Invitae Aims to Regain NYSE Compliance After Average Share Price Falls Below $1
Invitae Receives Notice of Non-Compliance With NYSE Minimum Share Price Continued Listing Standard
SAN FRANCISCO, Sept. 22, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it received a notice from the New York Stock Exchange (the "NYSE") on Sept
Novavax and Invitae Implement Cost-cutting Measures Amid Financial Challenges
Comments
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--